Buch, Englisch, 262 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 423 g
ISBN: 978-981-19-8467-9
Verlag: Springer Nature Singapore
This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Introduction to Adaptive Design and Delayed Outcomes.- Basics of Bayesian Statistics.- Phase I Dose-finding Design.- Phase II Design for Interim Monitoring.- Phase I-II Dose-finding Design.- Drug Combination Trial Design.- Conclusion.